![](/img/cover-not-exists.png)
FRI0408 Rituximab treatment reduces circulating th2 cells and il4 expression in the skin of patients with systemic sclerosis.
Antonopoulos, I., Liossis, S.-N., Daoussis, D., Tsamandas, A., Markatseli, T., Karatza, E., Drosos, A., Andonopoulos, A.Volume:
72
Language:
english
Journal:
Annals of the Rheumatic Diseases
DOI:
10.1136/annrheumdis-2013-eular.1535
Date:
June, 2013
File:
PDF, 253 KB
english, 2013